ZERONDA TYLER (Interim CFO) reported 1 transaction at VYNE THERAPEUTICS INC.
Review the transaction codes below to understand the nature of each event.
Filed: 4/3/2024ACC: 0001415889-24-010074
Officer· Interim CFO
Since Jun 2021
-94.00
Net shares
Net seller
$289.52
Total sold
0
Open market trades
0B · 0S
1
Total transactions
94.00 disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−94.00
Price / share
$3.08
Trade value
$289.52
% of position
0.1%
4/1/2024
131.84K→131.74K
Total
Net shares
−94.00
Net value
-$289.52
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 4/1/2024 | F · Tax Withholding | −94.00 | $3.08 | $289.52 | 0.1% | 131.84K | 131.74K |
| Total | −94.00 | -$289.52 | ||||||
Derivative Transactions0
No derivative transactions reported